News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|July 22, 2022

Safety, efficacy of berdazimer gel for molluscum contagiosum

Author(s)Kaitlyn Bader

Stephen Stripling, MD, FAAP, discusses results published in JAMA Dermatology about the efficacy and safety of berdazimer gel 10.3% for the treatment of molluscum contagiosum.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older

AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older

ByMorgan Ebert, Managing Editor

February 3rd 2026

Arcutis reports positive phase 2 data for roflumilast cream in infants with atopic dermatitis | Image Credit: © triocean - stock.adobe.com.

Arcutis reports positive phase 2 data for roflumilast cream (Zoryve) in infants with atopic dermatitis

ByMorgan Ebert, Managing Editor

February 2nd 2026

Phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years and older | Image Credit: © aboutnuylove - stock.adobe.com.

Results from phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years or older

ByMorgan Ebert, Managing Editor

January 23rd 2026

Survey highlights gaps in long-term management of chronic inflammatory skin disease | Image Credit: © Ruslan Ivantsov - stock.adobe.com.

Survey highlights gaps in long-term management of chronic inflammatory skin disease

ByMorgan Ebert, Managing Editor

January 21st 2026

INTEGUMENT-PED trial shows consistent efficacy of roflumilast cream in children aged 2 to 5

INTEGUMENT-PED trial shows consistent efficacy of roflumilast cream in children aged 2 to 5

ByVimal H. Prajapati, MD

January 20th 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Trending on Contemporary Pediatrics

Renuka Dias, PhD, MBBS, highlights feasibility of type 1 diabetes screening in children

FDA grants priority review to marstacimab (Hympavzi) for younger children and patients with hemophilia inhibitors

Infant botulism outbreak linked to powdered formula under FDA investigation

Top 5 pediatric health headlines you missed in January 2026

AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older